Evaxion A/S Files December 2025 6-K Report
Ticker: EVAX · Form: 6-K · Filed: Dec 10, 2025 · CIK: 1828253
| Field | Detail |
|---|---|
| Company | Evaxion A/S (EVAX) |
| Form Type | 6-K |
| Filed Date | Dec 10, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $45,527,824, $4,480,000, $4,472,175.80 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, regulatory-filing, foreign-private-issuer
Related Tickers: EVX
TL;DR
EVX files routine 6-K for Dec 2025, incorporating past filings.
AI Summary
Evaxion A/S filed a Form 6-K on December 10, 2025, reporting for the month of December 2025. The filing is a report of a foreign private issuer and incorporates by reference several of the company's registration statements, including those on Form S-8 and Form F-3, as well as multiple Form F-1 filings. The company's principal executive offices are located in Hoersholm, Denmark.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Evaxion A/S's status as a foreign private issuer, incorporating previous registration statements.
Risk Assessment
Risk Level: low — This is a routine filing that incorporates previous registration statements and does not appear to contain new material financial or operational information.
Key Players & Entities
- Evaxion A/S (company) — Registrant
- 001-39950 (dollar_amount) — Commission File Number
- 333-255064 (dollar_amount) — Form S-8 File Number
- 333-265132 (dollar_amount) — Form F-3 File Number
- 333-266050 (dollar_amount) — Form F-1 File Number
- 333-276505 (dollar_amount) — Form F-1 File Number
- 333-279153 (dollar_amount) — Form F-1 File Number
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a report of a foreign private issuer for the month of December 2025, and it incorporates by reference several of Evaxion A/S's registration statements.
What is the Commission File Number for Evaxion A/S?
The Commission File Number for Evaxion A/S is 001-39950.
Where are Evaxion A/S's principal executive offices located?
Evaxion A/S's principal executive offices are located at Dr. Neergaards Vej 5f, DK-2970 Hoersholm, Denmark.
Which registration statements are incorporated by reference in this filing?
This filing incorporates by reference registration statements on Form S-8 (File No. 333-255064), Form F-3 (File No. 333-265132), and multiple Form F-1 filings (File Nos. 333-266050, 333-276505, 333-279153).
What is the former name of Evaxion A/S?
The former name of Evaxion A/S was Evaxion Biotech A/S, with a date of name change on October 14, 2020.
Filing Stats: 585 words · 2 min read · ~2 pages · Grade level 12.1 · Accepted 2025-12-10 08:15:10
Key Financial Figures
- $45,527,824 — ng an aggregate offering price of up to $45,527,824, pursuant to that certain Capital on De
- $4,480,000 — relating to the offer and sale of up to $4,480,000 of ADSs pursuant to the Sales Agreement
- $4,472,175.80 — hereto. The Company has previously sold $4,472,175.80 of ADSs pursuant to the Sales Agreement
Filing Documents
- tm2533081d1_6k.htm (6-K) — 15KB
- tm2533081d1_ex5-1.htm (EX-5.1) — 29KB
- tm2533081d1_ex5-1img001.jpg (GRAPHIC) — 7KB
- 0001104659-25-119858.txt ( ) — 54KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Evaxion Biotech A/S Date: December 10, 2025 By: /s/ Dr. Helen Tayton-Martin Dr. Helen Tayton-Martin Chief Executive Officer